U.S. Healthtech Stock News

If you are wondering whether D.R. Horton is fairly priced or offering value at current levels, this breakdown will help you put the recent share price in context. The stock last closed at US$143.74, with recent returns of 2.9% over 7 days, a 1.1% decline over 30 days, a 1.4% decline year to date, and gains of 23.4% over 1 year, 51.1% over 3 years, and 62.4% over 5 years. Recent coverage around US homebuilding and housing supply has kept attention on the sector, as investors look at how...

If you are asking whether STAAR Surgical's current share price lines up with its underlying worth, the recent moves in the stock make that question especially timely. The shares last closed at US$25.21, with returns of 24.7% over the past week, 46.3% over the past month, 6.8% year to date, and 61.9% over one year, set against declines of 62.5% over three years and 79.0% over five years. This mix of strong shorter term returns and weaker longer term results means recent news and changing...

Wondering if Lincoln Electric Holdings at around US$256 per share still offers value after a strong run, or if expectations are already baked into the price. The stock currently trades at US$256.11, with returns of 5.1% over the last week, a 3.6% decline over the past month, 5.1% year to date, 46.7% over one year, 67.3% over three years and 124.2% over five years, which may catch your eye if you focus on long term performance and recent volatility. Recent coverage has focused on Lincoln...

Recent share performance and business mix Leidos Holdings (LDOS) has seen its share price retreat recently, with a 3.1% decline over the past day, around 2% over the past week, and close to 10% over the past month. That shorter term weakness follows a larger past 3 months pullback of roughly 21.5% and a year to date decline of about 15.2%, even as the 1 year total return remains positive at 12.5%. Behind the stock is a sizeable government and commercial services business, generating US$17.2b...

Why Ouster’s latest guidance has investors watching the next earnings call Ouster (OUST) has drawn fresh attention after management issued first quarter 2026 revenue guidance of US$45 million to US$48 million, above analyst expectations and incorporating the recent StereoLabs acquisition. This update, combined with twelve consecutive quarters of product revenue increases and higher software attached bookings in 2025, has put extra focus on the upcoming earnings report as investors look for...

Recent analyst commentary on Avery Dennison (AVY) has focused on weak consumer demand, rising costs, and sector headwinds, with some market participants highlighting the possibility of muted growth and a greater role for M&A in the year ahead. See our latest analysis for Avery Dennison. At a share price of US$173.81, Avery Dennison has a 1 year total shareholder return of 6.6%, but a 90 day share price return of a 7.7% decline signals fading momentum despite modest longer term gains. If you...

Analyst upgrade puts PJT Partners (PJT) back in focus PJT Partners (PJT) moved into the spotlight after Keefe, Bruyette & Woods shifted its rating to Outperform, highlighting the firm’s exposure to large cap and complex M&A advice as a key factor. See our latest analysis for PJT Partners. At a US$150.00 share price, PJT Partners has recently seen a 7.15% 7 day share price return and a 7.43% 30 day share price return. The 1 year total shareholder return of 16.68% sits against weaker year to...

The latest catalyst around Texas Instruments (TXN) is a high profile analyst upgrade to Buy, tied to stronger free cash flow, margin improvement, and expectations for an analog semiconductor upcycle. See our latest analysis for Texas Instruments. That upgrade has landed at a time when momentum is already strong, with the share price at US$214.98, a 21.1% year to date share price return and a 50.25% 1 year total shareholder return. This suggests improving sentiment toward TXN’s longer term...

Wondering if CVS Health at around US$78.84 is giving you fair value for the risk you are taking, or if the current price is leaving something on the table? The stock has a 7.3% return over the past 7 days and 3.3% over the last month, while the year to date return sits at a 1.6% decline and the 1 year return is 18.7%. Recent headlines have focused on CVS Health's positioning as a major integrated healthcare player and its ongoing efforts to balance its retail, pharmacy benefit, and health...

Conagra Brands (NYSE:CAG) is expanding its frozen portfolio with new high protein breakfast themed meals aimed at lunch and other non morning eating occasions. Recent launches include mini Tennessee Pride breakfast sandwiches and Banquet Mega breakfast bowls positioned for all day consumption. The move targets consumers who are increasingly eating traditional breakfast foods beyond the morning meal. For anyone tracking packaged food companies, this is a clear sign that Conagra Brands, the...

Price hikes in EMEA put Sonoco Products in focus Sonoco Products (SON) has moved to raise prices across key industrial packaging categories in Europe, the Middle East and Africa, responding to higher costs for energy, fuel and raw materials. See our latest analysis for Sonoco Products. The price increases in EMEA arrive at a time when Sonoco Products’ share price has built momentum, with a 30 day share price return of 5.24% and a 90 day gain of 18.44%. The 1 year total shareholder return...

If you are wondering whether ATI is offering value at today's price or if the story has already played out, this breakdown will help you frame what the current share price could mean for you. ATI closed at US$159.63, with returns of 8.9% over 7 days, 0.4% over 30 days, 33.9% year to date, 244.2% over 1 year and 308.8% over 3 years, while the 5 year return is about 7 times the starting point. Recent coverage around ATI has focused on how its share price performance compares with peers in the...

If you are wondering whether Antero Midstream’s share price still offers value at around US$22.21, you are not alone, many investors are asking the same question right now. The stock has had a mixed recent run, with a 2.4% decline over the last week and a 1.7% decline over the last month, yet it is still up 23.8% year to date and 47.2% over the past year. Those moves have put valuation under the spotlight again, as investors weigh up Antero Midstream’s role within the broader energy...

Mercury Insurance, part of Mercury General (NYSE:MCY), is promoting safe driving practices tied to spring rain conditions. The company is also sharing guidance during Distracted Driving Awareness Month to encourage more attentive driving. These initiatives focus on public safety messaging for policyholders and drivers more broadly. For a property and casualty insurer such as Mercury General, road safety is core to both customer outcomes and claims experience. By spotlighting the hazards of...

Earlier this month, Molina Healthcare reacted to the Centers for Medicare & Medicaid Services’ finalized 2027 Medicare Advantage payment rates, which lifted reimbursement levels across the industry and prompted the company to schedule an earnings call and investor day focused on valuation and margins. The news also drew attention to Molina’s heavy reliance on Medicaid and Medicare in large states such as California, New York, Texas, and Washington, where payment policy and cost trends can...

Adobe is confronting intensified AI-focused competition, a planned CEO transition with Shantanu Narayen set to step down, and fresh regulatory scrutiny tied to a major subscription settlement. At the same time, the company reports record AI-related revenue and AI first ARR growth, while rolling out new AI features for education customers. These parallel developments are reshaping the risk and opportunity profile for NasdaqGS:ADBE and drawing heightened investor attention. For investors...

Firmer analyst sentiment and rising earnings expectations have pushed Northern Trust (NTRS) into focus, as recent upgrades and consistent estimate beats shape how investors assess the bank’s wealth and asset management centered model. See our latest analysis for Northern Trust. At a share price of US$152.63, Northern Trust has seen a 7.30% 7 day share price return and a 10.62% 30 day share price return. Its 1 year total shareholder return of 77.93% shows that recent momentum has built on a...

If you are wondering whether Wells Fargo is attractively priced today or if the recent run leaves it in stretched territory, this breakdown will help you frame where value might actually sit. Wells Fargo shares last closed at US$86.02, with returns of 6.7% over 7 days, 9.9% over 30 days, a 9.6% decline year to date, and 39.3% over 1 year and 134.2% over 3 years, so recent moves have been far from quiet. Headlines around large U.S. banks, regulatory scrutiny and sector-wide shifts in capital...

In recent days, RBC Capital reiterated a bearish view on Pfizer, highlighting competitive and pricing pressures on key products including Paxlovid, Vyndamax, and Prevnar, alongside expectations for a year-over-year revenue decline. This renewed skepticism arrives as Pfizer pursues an extensive pipeline and acquisition program, sharpening the contrast between near-term product headwinds and longer-term portfolio ambitions. Against this backdrop, we’ll examine how RBC’s continued caution on...

If you are wondering whether Lockheed Martin is still fairly priced after a strong run, or if the stock is starting to look stretched, this article walks through the key numbers so you can judge the value for yourself. The stock last closed at US$623.87, with returns of 0.2% over the past week, a 4.2% decline over the past month, 25.5% year to date and 38.2% over the last year. Recent headlines have focused on Lockheed Martin's role in defense contracts and broader sector sentiment, which...

In recent days, WesBanco Inc. reported strong earnings and revenue momentum, with accelerating year-over-year EPS growth and top-line expansion above 60%, prompting analysts to raise their revenue estimates for the next year. This shift in expectations highlights how quickly improving fundamentals and analyst confidence can reshape perceptions of a regional bank’s growth potential. Next, we will examine how this acceleration in earnings and revenue growth reshapes WesBanco’s existing...

Business model pivot and fresh financing reshape the story Cipher Digital (CIFR) is undertaking a business reset, moving away from pure bitcoin mining toward building and leasing high performance computing data centers to hyperscale clients like Google and AWS. To support this shift, the company recently signed a 15-year lease with a major tenant and secured a revolving credit facility of up to US$250 million. These steps are intended to provide operating stability and funding capacity for...

Wondering if Crocs at around US$101.95 is offering value or asking too much for its future? This breakdown is designed to help you size up the stock with a clear valuation lens. The share price has delivered a 21.9% return over the last 7 days, 26.8% over the past month and 10.1% over the last year, while the 3 year return sits at a 24.1% decline and the 5 year return at 29.0%. Recent coverage has focused on Crocs as a consumer brand name in the market, including ongoing commentary on its...

Recent Price Moves and Valuation Snapshot Oil-Dri Corporation of America (ODC) has recently attracted attention after a period of strong share price performance, with the stock last closing at $72.78 and screening with an internal value score of 1. For context, the company reports annual revenue of $478.936 million and net income of $50.359 million. This implies investors are weighing that earnings base against a market capitalization of about $1.029 billion and a calculated intrinsic...